Clinical features of acquired resistance to anti–PD-1 therapy in advanced melanoma

Anti–PD-1 therapy has improved clinical outcomes in advanced melanoma, but most patients experience intrinsic resistance. Responding patients can develop acquired resistance to anti–PD-1. We retrospectively reviewed 488 patients treated with anti–PD-1 from three academic centers and identified 36 pa...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Immunol Res
Main Authors: Wang, Daniel Y., Eroglu, Zeynep, Ozgun, Alpaslan, Leger, Paul D., Zhao, Shilin, Ye, Fei, Luke, Jason J., Joseph, Richard W., Haq, Rizwan, Ott, Patrick A., Hodi, F. Stephen, Sosman, Jeffrey A., Johnson, Douglas B., Buchbinder, Elizabeth I.
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5502536/
https://ncbi.nlm.nih.gov/pubmed/28396509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-16-0287
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki